دورية أكاديمية

Significance of eosinophilia in granulomatosis with polyangiitis: data from the French Vasculitis Study Group Registry.

التفاصيل البيبلوغرافية
العنوان: Significance of eosinophilia in granulomatosis with polyangiitis: data from the French Vasculitis Study Group Registry.
المؤلفون: Iudici, Michele, Puéchal, Xavier, Pagnoux, Christian, Courvoisier, Delphine S, Hamidou, Mohamed, Blanchard-Delaunay, Claire, Maurier, François, Ruivard, Marc, Quéméneur, Thomas, Aumaître, Olivier, Guillevin, Loïc, Terrier, Benjamin, Group, for the French Vasculitis Study
المصدر: Rheumatology; Mar2022, Vol. 61 Issue 3, p1211-1216, 6p
مصطلحات موضوعية: WEGENER'S granulomatosis diagnosis, KIDNEY physiology, EOSINOPHILS, REPORTING of diseases, SKIN diseases, PATIENT aftercare, PERIPHERAL neuropathy, WEGENER'S granulomatosis, EOSINOPHILIA, DISEASE relapse, SEX distribution, DESCRIPTIVE statistics, SYMPTOMS
مستخلص: Objective To describe disease presentation and long-term outcome of granulomatosis with polyangiitis (GPA) patients according to blood eosinophils count (Eos) at vasculitis diagnosis. Methods Data from newly diagnosed GPA patients registered in the French Vasculitis Study Group database with available eosinophil count at diagnosis were reviewed. Disease characteristics, rate and type of relapses, and overall survival were analysed according to Eos, categorized as normal (<500/mm3), mild-to-moderate hypereosinophilia (HE) (between 500 and 1500/mm3) and severe HE (>1500/mm3). Results Three hundred and fifty-four patients were included. At diagnosis, 90 (25.4%) patients had HE ≥500/mm3; they were more likely male (73% vs 56%, P  = 0.006) and had more frequent cutaneous manifestations (49% vs 33%, P  = 0.01), peripheral neuropathy (32% vs 17%, P  = 0.004) and higher BVAS (21 vs 18, P  = 0.01), compared with those with Eos <500/mm3. Patients with severe HE (n  = 28; median Eos 2355, range 1500–9114) had more frequent renal function worsening at presentation (P  = 0.008). After a median follow-up of 3.95 (interquartile range 1.95–6.76) years, no difference was found in overall relapse rates according to baseline Eos, but those with HE experienced more neurological (P  = 0.013) and skin (P  = 0.024) relapses and had more frequently peripheral neuropathy as damage at last follow-up (P  = 0.02). Overall survival was not significantly different in patients with normal Eos or HE at diagnosis. (P  = 0.08). Conclusions Blood HE at diagnosis, observed in about one-quarter of GPA patients, identifies a subgroup of patients with a more severe disease and higher rate of skin and neurological involvement both at presentation and during follow-up. [ABSTRACT FROM AUTHOR]
Copyright of Rheumatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14620324
DOI:10.1093/rheumatology/keab495